Valuation: Thor Medical

Market Cap 1.69B 179M 161M 147M 134M 253M 16.86B 261M 1.77B 707M 9B 673M 659M 28.41B P/E 2026 *
-18.7x
P/E 2027 * -72.9x
Enterprise Value 1.69B 179M 160M 147M 134M 252M 16.81B 260M 1.77B 705M 8.97B 671M 657M 28.32B EV / Sales 2026 *
88.9x
EV / Sales 2027 * 11.5x
Free-Float
75.21%
Yield 2026 *
-
Yield 2027 * -
1 day+2.62%
1 week+2.49%
Current month+2.49%
1 month-6.90%
3 months-22.36%
6 months-8.35%
Current year-21.62%
1 week 3.7
Extreme 3.7
4.24
1 month 3.7
Extreme 3.7
4.6
Current year 3.7
Extreme 3.7
7.12
1 year 3.48
Extreme 3.485
7.12
3 years 0.85
Extreme 0.85
7.12
5 years 0.85
Extreme 0.85
7.12
10 years 0.85
Extreme 0.85
7.12
Manager TitleAgeSince
Chief Executive Officer 41 01/08/2024
Director of Finance/CFO 37 01/07/2023
Chief Tech/Sci/R&D Officer - 01/06/2023
Director TitleAgeSince
Director/Board Member 67 28/06/2023
Chairman 59 -
Director/Board Member - 24/04/2025
Date Insider Type Main position Quantity % Market Cap. Importance
26/6/25
Scatec Innovation AS
OthersCompany 31,577,399 10.0434%
18/6/25
Scatec Innovation AS
BuyCompany 3,000,000 0.9542%
2/5/25 Exercice

Director

164,641 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
+2.62%+2.49%+11.07%+220.98% 182M
-4.83%+2.88%+55.87%+69.12% 69.4B
+0.02%+1.07%+10.63%+76.66% 57.24B
-1.34%+2.98%+24.79%+100.18% 57.62B
+2.57%+2.19%+29.56%+37.70% 43.65B
+4.96%+10.49%+23.11%+108.62% 44.03B
+8.65%+1.57%+216.58%+802.11% 38.08B
-1.86%+11.46%+26.67%+61.40% 36.31B
-2.97%-9.84%+88.86%+76.17% 32.61B
-2.18%+5.68%+36.21%-0.69% 25.47B
Average +0.56%+1.53%+52.34%+155.23% 40.46B
Weighted average by Cap. +0.08%+2.43%+52.55%+140.05%

Financials

2026 *2027 *
Net sales 19M 2.01M 1.8M 1.65M 1.51M 2.84M 189M 2.93M 19.88M 7.93M 101M 7.55M 7.39M 319M 143M 15.17M 13.6M 12.43M 11.35M 21.38M 1.43B 22.06M 150M 59.76M 761M 56.93M 55.71M 2.4B
Net income -80.5M -8.52M -7.65M -6.99M -6.38M -12.02M -801M -12.4M -84.22M -33.58M -428M -31.99M -31.31M -1.35B -23.5M -2.49M -2.23M -2.04M -1.86M -3.51M -234M -3.62M -24.59M -9.8M -125M -9.34M -9.14M -394M
Net Debt -5M -529K -475K -434K -396K -746K -49.77M -770K -5.23M -2.09M -26.56M -1.99M -1.94M -83.83M -43.5M -4.61M -4.13M -3.78M -3.45M -6.49M -433M -6.7M -45.51M -18.15M -231M -17.29M -16.92M -729M
Projected Income Statement - Annual - Thor Medical
Logo Thor Medical
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Employees
24
Date Price Change Volume
07/11/26 NOK 4.115 +2.62% 2,370,142
05/11/26 NOK 4.010 -3.37% 1,390,212
04/11/26 NOK 4.150 +0.73% 2,471,490
03/11/26 NOK 4.120 +4.57% 2,529,935
02/11/26 NOK 3.940 -1.87% 2,716,946
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.010NOK
Average target price
5.600NOK
Spread / Average Target
+39.65%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Thor Medical
  1. Stock Market
  2. Stocks
  3. NANOV Stock